Cancer clinical trials in the region Hauts-de-France
146 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
ALK
None
Systemic Treatment-Naive
Surgery
Hoffmann-La Roche
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
ALK
EGFR
Bristol-Myers Squibb
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Phase 3
Lymphoma
Chronic lymphocytic leukemia
#NCT06428019
B cell lymphoma
Lymphocytic lymphoma
> 60 ml/min
50-60 ml/min
30-50 ml/min
Systemic Treatment-Naive
CHU Amiens-Picardie (Amiens)
Abbvie
Phase 3
Endometrial cancer
#NCT06132958
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Carcinosarcoma
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Centre Oscar Lambret (Lille)
Merck Sharp & Dohme LLC
Phase 3
Breast cancer
#NCT05232916
HER2 Positive
Localized
Locally Advanced
None
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Hospitalier Simone Veil de Beauvais (Beauvais)
Greenwich LifeSciences, Inc.
Phase 3
Lung cancer
#NCT06646276
SCLC (Small Cell Lung Cancer)
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
Bristol-Myers Squibb